LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
Elekta AB
Headquarters:
Stockholm, Sweden
Website:
http://www.elekta.com
Year Founded:
1972
Status:
Public
Industry Sector:
HealthTechnology
CEO:
Jonas Bolander
Number Of Employees:
4,641
Enterprise Value:
$3,168,519,439
PE Ratio:
21.05
Exchange/Ticker 1:
SSE:EKTA B
Exchange/Ticker 2:
N/A
Latest Market Cap:
$2,140,018,020
BioCentury
|
Feb 28, 2025
Management Tracks
Indivior CEO exits as activist shareholder Oaktree presses for change
Plus: Paul Hitchin succeeds Laetitia Rouxel as CFO of Evotec, and updates from Elekta, Forx, Abzena and more
Read More
Items per page:
10
1 - 1 of 1
Help Center
Username
Request a Demo
Request Training
Ask a Question
Elevio by Dixa
Help